Growing community of inventors

Zurich, Switzerland

Michael Huber

Average Co-Inventor Count = 14.01

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 27

Michael HuberJennifer L Mitcham (6 patents)Michael HuberDennis R Burton (6 patents)Michael HuberOle Olsen (6 patents)Michael HuberMatthew Moyle (6 patents)Michael HuberPo-Ying Chan-Hui (6 patents)Michael HuberSanjay K Phogat (6 patents)Michael HuberWayne C Koff (6 patents)Michael HuberSteven Frey (6 patents)Michael HuberStephen Kaminsky (6 patents)Michael HuberPascal Raymond Georges Poignard (6 patents)Michael HuberMelissa Danielle De Jean De St Marcel Simek-Lemos (6 patents)Michael HuberKatherine Doores (6 patents)Michael HuberLaura Majorie Walker (4 patents)Michael HuberLaura Marjorie Walker (2 patents)Michael HuberKatherine Doores (0 patent)Michael HuberMelissa Danielle Simek-Lemos (0 patent)Michael HuberMichael Huber (6 patents)Jennifer L MitchamJennifer L Mitcham (60 patents)Dennis R BurtonDennis R Burton (53 patents)Ole OlsenOle Olsen (33 patents)Matthew MoyleMatthew Moyle (32 patents)Po-Ying Chan-HuiPo-Ying Chan-Hui (27 patents)Sanjay K PhogatSanjay K Phogat (25 patents)Wayne C KoffWayne C Koff (25 patents)Steven FreySteven Frey (21 patents)Stephen KaminskyStephen Kaminsky (19 patents)Pascal Raymond Georges PoignardPascal Raymond Georges Poignard (16 patents)Melissa Danielle De Jean De St Marcel Simek-LemosMelissa Danielle De Jean De St Marcel Simek-Lemos (14 patents)Katherine DooresKatherine Doores (6 patents)Laura Majorie WalkerLaura Majorie Walker (4 patents)Laura Marjorie WalkerLaura Marjorie Walker (10 patents)Katherine DooresKatherine Doores (0 patent)Melissa Danielle Simek-LemosMelissa Danielle Simek-Lemos (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The Scripps Research Institute (6 from 1,186 patents)

2. International Aids Vaccine Initiative (6 from 68 patents)

3. Theraclone Sciences, Inc. (6 from 28 patents)


6 patents:

1. 12410243 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

2. 11845789 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

3. 11319362 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

4. 10836811 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

5. 10087239 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

6. 9464131 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…